Literature DB >> 29736740

Tamoxifen-induced fatty liver disease in a Caucasian patient.

Karel Eechoute1, Ron H J Mathijssen2, Teun van Gelder2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29736740     DOI： 10.1007/s10549-018-4817-8

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  2 in total

1.  Tamoxifen use and potential effects on liver parenchyma: A long-term prospective transient elastographic evaluation.

Authors:  C Louwrens Braal; Robert J de Knegt; Agnes Jager; Stijn L W Koolen; Ron H J Mathijssen; Karel Eechoute
Journal:  Hepatol Commun       Date:  2022-06-10

2.  Inducible Systemic Gcn1 Deletion in Mice Leads to Transient Body Weight Loss upon Tamoxifen Treatment Associated with Decrease of Fat and Liver Glycogen Storage.

Authors:  Jun Liu; Shuya Kasai; Yota Tatara; Hiromi Yamazaki; Junsei Mimura; Seiya Mizuno; Fumihiro Sugiyama; Satoru Takahashi; Tsubasa Sato; Taku Ozaki; Kunikazu Tanji; Koichi Wakabayashi; Hayato Maeda; Hiroki Mizukami; Yasuhiro Shinkai; Yoshito Kumagai; Hirofumi Tomita; Ken Itoh
Journal:  Int J Mol Sci       Date:  2022-03-16       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.